One study found that out of 18 patients with SLE and thrombocytopenia, 14 had anticardiolipin (aCL) antibodies and the relative risk for thrombocytopenia in patients with aCL antibodies was greater than four [32]. The gene discussed is ACLY; the disease is systemic lupus erythematosus.